Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Thailand New upcoming elections could change cannabis regulations…
  • North Dakota - United States Amended bill would regulate revocation of medical cannabis patients’ ID cards& ...
  • Oklahoma - United States Senate bill to keep grow facilities from places of worship heads to House…
  • Montana - United States Bill to make delta-8 a controlled substance goes to governor…
  • Brazil Superior court to decide on hemp cultivation for medical purposes…
  • Canada Cannabis fees rise in line with inflation…
  • Kentucky - United States Bill to ban delta-8 sales to under-21s land on governor’s desk…
  • Oklahoma - United States House approves extension to Medical Marijuana Authority’s powers…
  • Spain Podemos and allies call for hemp regulation…
  • Belgium Positive notifications list updated…
  • Bulgaria Industrial cannabis THC limit could be increased…
  • Germany Public hearing held over decriminalising cannabis…
View all
News analysis

US FDA issues warning letter over COVID-19 health claims

Written by || 30th October 2020 || News analysis | Companies | Health and science | North America United States

The US Food and Drink Administration (FDA) has issued a warning letter to the CBD company For Our Vets over COVID-19 health claims ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents
US FDA takes action over unapproved drugs and unproven health claims
More CBD companies land in hot water with US FDA over COVID-19 claims
Unheeded FDA warning puts US firm in court over medical claims for CBD

CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.

© 2023 Tamarind Media Limited (T/A CannIntelligence)
CannIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CannIntelligence, does not accept any liability or responsibility for information or views published.